201
|
Mazzone E, Fossati N, Karnes R, Boorjan S, Motterle G, Bossi A, Kumar T, Di Muzio N, Cozzarini C, Noris Chiorda B, Gandaglia G, Stabile A, Scuderi S, Bartkowiak D, Shariat S, Goldner G, Joniau S, Van Poppel H, Berghen C, De Meerleer G, Montorsi F, Wiegel T, Briganti A. There is no way to compensate a non-timely use of early salvage radiation therapy in men with recurrent Prostate Cancer after Radical Prostatectomy. A retrospective, multi-centre analyses on oncological and toxicity outcomes. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01552-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
202
|
Sironi M, Leni R, Gandaglia G, Fossati N, Foti S, Fodor A, De Antoni C, Clerici S, Montorsi F, Briganti A. The role of a digital psychological support for prostate cancer patients managed by a multidisciplinary disease unit: Initial experience from a referral center. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01360-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
203
|
Rosiello G, Gandaglia G, Fossati N, Stabile A, Cucchiara V, Scuderi S, Barletta F, Martini A, Mazzone E, Bravi C, Robesti D, Cannoletta D, Sciacqua L, Comana S, Camisassa E, Gallina A, Montorsi F, Briganti A. Reducing the risk of postoperative complications after robot-assisted radical prostatectomy in prostate cancer patients: results of a prospective audit and feedback intervention following the implementation of prospective data collection. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00709-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
204
|
Stabile A, Mazzone E, Barletta F, Cucchiara V, Bravi C, Martini A, Rosiello G, Colandrea G, Scuderi S, Sorce G, Pellegrino F, Leni R, Pinar U, Seisen T, Roupret M, Karnes J, Esposito A, Gandaglia G, Fossati N, De Cobelli F, Montorsi F, Briganti A. Saturation of the mpMRI lesion is not necessary to minimize the risk of missing clinically significant prostate cancer at targeted biopsy. Analysis of a large, multi-institutional series. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01376-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
205
|
Dell’Oglio P, Mazzone E, Grivas N, Wit E, Donswijk M, Briganti A, Van Leeuwen F, Van Der Poel H. Diagnostic value, oncological outcomes and safety profile of image-guided surgery technologies during robot-assisted lymph node dissection with sentinel node biopsy for prostate cancer. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01296-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
206
|
Wenzel M, Würnschimmel C, Nocera L, Collà Ruvulo C, Shariat S, Briganti A, Graefen M, Kluth L, Mandel P, Chun F, Karakiewicz P. The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01586-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
207
|
Gandaglia G, Robesti D, Fossati N, Barletta F, Scuderi S, Rosiello G, Necchi A, Cucchiara V, Mazzone E, Capitanio U, Salonia A, Larcher A, Karakiewicz P, Montorsi F, Briganti A. Identification of the best candidates for PSMA PET/CT among patients experiencing biochemical recurrence after radical prostatectomy. A new tool to optimize of Patient Selection. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01545-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
208
|
Fossati N, Karnes J, Boorjian S, Motterle G, Bossi A, Kumar T, Di Muzio N, Cozzarini C, Noris Chiorda B, Mazzone E, Robesti D, Gandaglia G, Bartkowiak D, Shariat S, Goldner G, Joniau S, Van Poppel H, Berghen C, De Meerleer G, Montorsi F, Wiegel T, Briganti A. The key role of PSA doubling time in patients treated with salvage radiation therapy after radical prostatectomy: Implications for the extent of radiation and the concomitant use of hormonal therapy. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01554-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
209
|
Beyer K, Moris L, Lardas M, Haire A, Barletta F, Scuderi S, Molnar M, Herrera R, Rauf A, Campi R, Greco I, Shiranov K, Dabestani S, Van Den Broeck T, Gacci M, Gandaglia G, Omar M, Maclennan S, Roobol M, Zong J, Maclennan S, Collette L, Briganti A, Bjartell A, Van Hemelrijck M. Diagnostic and prognostic factors in patients with prostate cancer. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00685-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
210
|
Cozzarini C, Magli A, Cante D, Noris Chiorda B, Munoz F, Faiella A, Olivetta E, Signor M, Piva C, Avuzzi B, Ferella L, Pastorino A, Fodor A, Deantoni C, Nicola F, Gandaglia G, Sanguineti G, Valdagni R, Fiorino C, Briganti A, Montorsi F, Di Muzio N. Independent role of dose-escalation and prophylactic lymph-nodal irradiation in salvage radiotherapy after prostatectomy. A retrospective, multi-institute analysis on 725 men treated with high-dose radiotherapy and eight years follow-up. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01555-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
211
|
Bravi C, Fossati N, Gandaglia G, Motterle G, Karnes R, Pfister D, Heidenreich A, Kretschmer A, Stief C, Devos G, Joniau S, Van Poppel H, Osmonov D, Juenemann K, Grubmüller B, Shariat S, Nini A, Hiester A, Albers P, Tilki D, Graefen M, Gill I, Mottrie A, Montorsi F, Briganti A. Identifying the optimal candidates for radiation therapy after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Results from a multi-institutional collaboration. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01563-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
212
|
Leni R, Gandaglia G, Nocera L, Stabile A, Fossati N, Bandini M, Toneatto L, Basile G, Martini A, Pellegrino F, Mazzone E, Rosiello G, De Cobelli F, Montorsi F, Briganti A. Development of novel criteria to identify the optimal candidates for active surveillance among men with low-risk prostate cancer and a positive family history. Results from a large, single institution series. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01403-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
213
|
Nocera L, Gandaglia G, Fossati N, Stabile A, Cucchiara V, Mazzone E, Bravi C, Rosiello G, Sorce G, Pellegrino F, Scuderi S, Barletta F, Cirulli G, Colombo R, Montorsi F, Briganti A. Identifying the most informative cut-off of psa to define biochemical recurrence after radical prostatectomy: A stage-by-stage analysis. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01540-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
214
|
Cirulli G, Martini A, Pellegrino F, Scuderi S, Parikh A, Oh W, Sfakianos J, Karakiewicz P, Galsky M, Tsao C, Cucchiara V, Stabile A, Gandaglia G, Fossati N, Necchi A, Montorsi F, Briganti A. Balancing efficacy and toxicity of docetaxel in patients with metastatic castration-resistant prostate cancer. Results from a pooled analysis of three prospective randomized trials. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01234-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
215
|
Pellegrino F, Mazzone E, Stabile A, Sorce G, Nocera L, Scuderi S, Basile G, Colandrea G, Leni R, Cannoletta D, De Angelis M, Pellegrino A, Sciacqua L, Comana S, Camisassa E, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Assessing the need for systematic biopsies in addition to targeted biopsies according to the volume of the index lesion diagnosed at mpmri. Results from a large multi-institutional database. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01378-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
216
|
Stabile A, Mazzone E, Barletta F, Bravi C, Rosiello G, Cucchiara V, Sorce G, Pellegrino F, Zaffuto E, Brembilla G, Esposito A, Gandaglia G, Fossati N, Gallina A, Dehò F, De Cobelli F, Montorsi F, Briganti A. The learning curve of mpMRI targeted biopsy for the detection of clinically significant prostate cancer is related to the characteristics of the index lesion. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01314-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
217
|
Rosiello G, Gandaglia G, Fossati N, Scuderi S, Martini A, Barletta F, Stabile A, Cucchiara V, Bravi C, Robesti D, Cannoletta D, Pellegrino A, Camisassa E, Comana S, Sciacqua L, Mazzone E, Montorsi F, Briganti A. Development of a classification system for reporting postoperative complications in prostate cancer patients treated with robot-assisted radical prostatectomy: A comprehensive analysis based on the EAU guidelines recommendations. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00711-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
218
|
Mantica G, Suardi N, Smelzo S, Esperto F, Papalia R, Larocca R, Napolitano L, Oderda M, Ennas M, Stabile A, De Cobelli F, Briganti A, Introini C, Gontero P, Gaboardi F, Scarpa R, Mirone V, Montorsi F, Terrone C, Cardone G. Are urologists ready for interpretation of multiparametric MRI findings? A prospective multicentric evaluation. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01288-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
219
|
Stabile A, Gandaglia G, Fossati N, Sorce G, Pellegrino F, Nocera L, Scuderi S, Cirulli G, Cucchiara V, Zaffuto E, Leni R, Cannoletta D, De Angelis M, Comana S, Brembilla G, Esposito A, De Cobelli F, Montorsi F, Briganti A. How to follow patients with negative targeted prostate biopsy but positive multi-parametric MRI? Results from a large, single institution series. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01278-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
220
|
Lonati C, Afferi L, Baumeister P, Minervini A, Mari A, Krajewski W, Borghesi M, Rink M, Montorsi F, Briganti A, Hurle R, Contieri R, Umari P, Klatte T, Teoh JC, Soria F, Simeone C, Zamboni S, Roumiguié M, Rouprêt M, Masson-Lecomte A, Einerhand S, Mattei A, Moschini M. Survival outcomes of urothelial carcinoma with squamous differentiation versus pure squamous cell carcinoma. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01111-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
221
|
Nocera L, Gandaglia G, Leni R, Mazzone E, Bravi C, Martini A, Rosiello G, Scuderi S, Barletta F, Cannoletta D, Cirulli G, De Angelis M, Sciacqua L, Camisassa E, Stabile A, Fossati N, Montorsi F, Briganti A. The detection of a PI-RADS 4-5 lesion at multiparametric MRI before confirmatory biopsy. Is the strongest predictor of disease progression among men with low-risk prostate cancer included in an active surveillance prospective protocol. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01305-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
222
|
Lonati C, Baumeister P, Afferi L, Mari A, Minervini A, Krajewski W, Einerhand S, Montorsi F, Briganti A, Antonelli A, Rouprêt M, Masson-Lecomte A, Shariat S, D’Andrea D, Soria F, Hurle R, Mir M, Zamboni S, Simeone C, Klatte T, Teoh J, Schulz G, Mattei A, Moschini M. Survival outcomes after radical cystectomy versus conservative management for clinical T1 high grade non-muscle invasive micropapillary bladder cancer: A multicenter collaboration by the European Association of Urology–Young Academic Urologists. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01126-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
223
|
Bravi C, Fossati N, Gandaglia G, Motterle G, Karnes R, Pfister D, Heidenreich A, Kretschmer A, Buchner A, Stief C, Devos G, Joniau S, Van Poppel H, Osmonov D, Jueneman KP, Grubmuller B, Shariat S, Hiester A, Albers P, Tilki D, Graefen M, Gill I, Mottrie A, Montorsi F, Briganti A. Definition and impact on oncologic outcomes of persistently elevated PSA after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Clinical Implications for multi-modal therapy. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01562-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
224
|
Tutolo M, Rosiello G, Van Der Aa F, Stabile G, Oreggia D, Barletta F, Scuderi S, Cannoletta D, De Wever L, De Ridder D, Tasso G, Everaerts W, Esposito A, De Cobelli F, Salonia A, Montorsi F, Briganti A. The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional study. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01533-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
225
|
Ventimiglia E, Villa L, Abbate C, Proietti S, Giusti G, Traxer O, Briganti A, Montorsi F, Salonia A. The use of ureteral access sheath does not reduce the rate of infectious complications after flexible ureteroscopy and Ho:YAG laser lithotripsy for renal stones. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00671-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
226
|
Zublena F, Briganti A, De Gennaro C, Corletto F. Ultrasound-guided parasternal injection in dogs: a cadaver study. Vet Anaesth Analg 2021; 48:563-569. [PMID: 34059462 DOI: 10.1016/j.vaa.2020.12.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 11/09/2020] [Accepted: 12/30/2020] [Indexed: 10/21/2022]
Abstract
OBJECTIVES To describe the technique of performing an ultrasound-guided distal parasternal intercostal block and to determine the distribution of two volumes of methylene blue dye solution injected in canine cadavers. STUDY DESIGN Prospective cadaver study. ANIMALS A group of seven canine cadavers weighing 12-34 kg. METHODS The space between the transversus thoracic and the internal intercostal muscles is a virtual cavity. Ultrasound-guided injections in the distal (parasternal) intercostal space were performed using dye solution at 0.05 mL kg-1 in each intercostal space from the second to seventh (LV, low volume, six injections per dog) in one hemithorax, and 0.1 mL kg-1 in the third, fifth and seventh intercostal spaces (HV, high volume, three injections in each dog) on the contralateral side. Anatomical dissection was carried out to describe dye spread characteristics and staining of intercostal nerves. RESULTS The ultrasonographic landmarks for injection were identified in each cadaver. In the LV group the solution was found in every intercostal space (36/36), whereas the HV injection stained six intercostal spaces in two dogs, five in two, and in two dogs the solution was found in four and three spaces, respectively, demonstrating multisegmental distribution. Intrapleural staining was observed after two injections. CONCLUSIONS AND CLINICAL RELEVANCE Ultrasound-guided injection of 0.05 mL kg-1 at the distal intercostal space resulted in staining of the intercostal nerve in all dogs when performed in every space and may be an appropriate alternative to previously reported techniques. A single injection of 0.1 mL kg-1 may anaesthetize more than one intercostal nerve, but not consistently. Clinical investigations are warranted to better characterize and to refine this locoregional technique.
Collapse
|
227
|
Marandino L, Raggi D, Calareso G, Alessi A, Colecchia M, Martini A, Briganti A, Montorsi F, Madison R, Ross JS, Necchi A. Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial. Clin Genitourin Cancer 2021; 19:457-465. [PMID: 34006499 DOI: 10.1016/j.clgc.2021.04.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Revised: 03/27/2021] [Accepted: 04/05/2021] [Indexed: 12/20/2022]
Abstract
BACKGROUND Durvalumab and cabozantinib have shown single-agent activity in patients with metastatic urothelial carcinoma (UC). ARCADIA is a phase 2 study evaluating their combination in patients with platinum-treated, advanced UC (NCT03824691). Herein, we report the results of the planned interim safety analysis and the preliminary activity. PATIENTS AND METHODS Patients with Eastern Cooperative Oncology Group Performance Status (ECOG PS) 0 or 1, UC and non-UC histology, and failure of a maximum of two regimens received cabozantinib 40 mg daily, orally, in combination with durvalumab 1500 mg, intravenously, every 28 days. Response was evaluated by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 every two cycles and by fluorodeoxyglucose positron emission tomography (FDG-PET) scans. RESULTS As of August 20, 2020, 16 patients were enrolled with a median follow-up of 6.7 months (range, 2-11). Four patients (25%) had ECOG PS 1 and had received two prior regimens. No grades 3 or 4 treatment-related adverse events (TRAEs) occurred within the first two cycles. The most common grades 1 and 2 TRAEs were fatigue (7, 43.8%), diarrhea (5, 31.3%), and dysphonia (5, 31.3%). Objective responses were seen in six patients (37.5%; 95% confidence interval, 15.2-64.6), including two complete responses (12.5%). One additional patient with bone-only disease obtained a decrease in FDG uptake and in circulating tumor DNA consistent with response. Angiogenesis-related gene alterations were found in 57% responders versus 0% nonresponders. CONCLUSION The durvalumab and cabozantinib combination was safe and endowed with preliminary clinical activity in patients with advanced UC. Mature results will clarify the role of cabozantinib and that of tumor biomarkers in this tumor type.
Collapse
|
228
|
Vitale V, Bonelli F, Briganti A, Sgorbini M. Bronchoalveolar lavage fluid cytological findings in healthy Amiata donkeys. Open Vet J 2021; 11:160-164. [PMID: 33898298 PMCID: PMC8057225 DOI: 10.4314/ovj.v11i1.23] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Accepted: 02/03/2021] [Indexed: 11/23/2022] Open
Abstract
Background: The approach to respiratory diseases in donkeys is similar to that for horses; nevertheless, Bronchoalveolar lavage fluid (BALF) and tracheal wash cytology in this species have been described only a few times in the literature. Aim: To describe BALF cytological findings in a cohort of 24 healthy Amiata donkeys. Methods: Bronchoalveolar lavage (BAL) was carried out via standing sedation with a large animal where the BAL catheter passed blindly through the nasal passage into the trachea. Results: The total nucleated cell count of the BALF was found similar to that already described in healthy horses and donkeys. No differences in the differential count were observed according to age and sex. A decreased macrophage percentage and an increased eosinophil percentage were observed in our donkey population when compared to the existing reference range for horses. Conclusion: The reference intervals for BAL cytology in donkeys may be significantly different for those referred for horses.
Collapse
|
229
|
Tramonti Fantozzi MP, Lazzarini G, De Cicco V, Briganti A, Argento S, De Cicco D, Barresi M, Cataldo E, Bruschini L, d'Ascanio P, Pirone A, Lenzi C, Vannozzi I, Miragliotta V, Faraguna U, Manzoni D. The path from trigeminal asymmetry to cognitive impairment: a behavioral and molecular study. Sci Rep 2021; 11:4744. [PMID: 33637775 PMCID: PMC7910455 DOI: 10.1038/s41598-021-82265-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Accepted: 01/15/2021] [Indexed: 01/02/2023] Open
Abstract
Trigeminal input exerts acute and chronic effects on the brain, modulating cognitive functions. Here, new data from humans and animals suggest that these effects are caused by trigeminal influences on the Locus Coeruleus (LC). In humans subjects clenching with masseter asymmetric activity, occlusal correction improved cognition, alongside with reductions in pupil size and anisocoria, proxies of LC activity and asymmetry, respectively. Notably, reductions in pupil size at rest on the hypertonic side predicted cognitive improvements. In adult rats, a distal unilateral section of the trigeminal mandibular branch reduced, on the contralateral side, the expression of c-Fos (brainstem) and BDNF (brainstem, hippocampus, frontal cortex). This counterintuitive finding can be explained by the following model: teeth contact perception loss on the lesioned side results in an increased occlusal effort, which enhances afferent inputs from muscle spindles and posterior periodontal receptors, spared by the distal lesion. Such effort leads to a reduced engagement of the intact side, with a corresponding reduction in the afferent inputs to the LC and in c-Fos and BDNF gene expression. In conclusion, acute effects of malocclusion on performance seem mediated by the LC, which could also contribute to the chronic trophic dysfunction induced by loss of trigeminal input.
Collapse
|
230
|
Busechian S, Sgorbini M, Orvieto S, Pisello L, Zappulla F, Briganti A, Nocera I, Conte G, Rueca F. Evaluation of a questionnaire to detect the risk of developing ESGD or EGGD in horses. Prev Vet Med 2021; 188:105285. [PMID: 33530014 DOI: 10.1016/j.prevetmed.2021.105285] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Revised: 01/19/2021] [Accepted: 01/21/2021] [Indexed: 12/23/2022]
Abstract
Equine gastric ulcer syndrome (EGUS) affects various categories of horses worldwide. This syndrome is now divided into two different diseases, based on the presence of lesions on either the squamous (Equine Squamous Gastric Disease, ESGD) or the glandular (Equine Glandular Gastric Disease, EGGD) mucosa. Diagnosis is based on the evaluation of the presence of gastric lesions with gastroscopic examination. As a gastroscopy can be considered expensive by clients, therapy is started often on the basis of clinical signs only. The aim of this study was to validate a questionnaire to detect the risk of developing ESGD or EGGD. The owners of 418 horses that were submitted to gastroscopic evaluation were asked to answer a questionnaire on risk factors for ESGD and EGGD. Horses were divided into three groups based on the results of the questionnaire and their risk of developing gastric lesions. In our population the survey was not useful to detect the presence and the severity of the lesions detected during gastroscopic examination, however answers to some of the questions did correlate with the development of gastric lesions. The questionnaire could therefore be a useful tool to evaluate the risk of ESGD or EGGD. Having owners periodically complete the survey could also make them more aware of changes in the conditions of the horses that could lead to gastric lesions. This could then help them seek advice from veterinarians on how to manage this potential risk.
Collapse
|
231
|
Pacini MI, Bonelli F, Briganti A, Citi S, Perrucci S, Papini RA, Sgorbini M. Corrigendum: Wildlife Ungulate Rescue and Emergency Services in the Pisa Area (Tuscany, Italy): Evaluation of a 9-Years Period (2010-2018). Front Vet Sci 2021; 7:629099. [PMID: 33490141 PMCID: PMC7820938 DOI: 10.3389/fvets.2020.629099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Accepted: 12/11/2020] [Indexed: 11/13/2022] Open
Abstract
[This corrects the article DOI: 10.3389/fvets.2020.00626.].
Collapse
|
232
|
Necchi A, Raggi D, Gallina A, Bandini M, Giannatempo P, Marandino L, Colecchia M, Briganti A, Montorsi F, Davicioni E, Lotan Y, Gibb EA. Molecular subtyping and immune-gene signatures identify a subset of clinical T1 high-grade (cT1 HG) and cT2 bladder urothelial carcinoma (UC) as candidates for single-agent immune checkpoint inhibition (ICI). Urol Oncol 2020. [DOI: 10.1016/j.urolonc.2020.10.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
233
|
Di Franco C, Tayari H, Nardi S, Briganti A. Along or across the visual axis: a comparison of two ultrasound screen, needle and transducer orientation techniques. Vet Anaesth Analg 2020; 48:147-150. [PMID: 33303397 DOI: 10.1016/j.vaa.2020.08.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2019] [Revised: 06/30/2020] [Accepted: 08/25/2020] [Indexed: 10/23/2022]
Abstract
OBJECTIVE To evaluate two transducer and needle handling methods, along the visual axis (AL) and across the visual axis (AC), in non-skilled and skilled clinicians. STUDY DESIGN Prospective randomized crossover study. METHOD A total of 26 students with no ultrasound locoregional anaesthesia experience (non-skilled group) and six clinicians experienced and familiar with ultrasound locoregional anaesthesia (skilled group) were enrolled. The non-skilled group was asked to perform two tasks: the first on a phantom and the second on canine cadavers, whilst the skilled group performed only the second task. The tasks consisted of guiding the tip of the needle to a target point (simulated nerve on the jelly phantom and sciatic nerve on the cadavers) using two different methods of needle handling-AL or AC. All operators performed each task three times for each method. The time to drive the needle to the target for the two methods was analysed with a paired Student t test, and the number of times the needle was not visualized on the screen between the groups was compared using an unpaired Student t test. Data are presented as mean ± standard deviation. Value of p < 0.05 was considered significant. RESULTS The AL method, compared with the AC method, resulted in shorter performance time in both skilled (9 ± 5 versus 20 ± 8 seconds for the second task) and non-skilled groups (9 ± 8 versus 17 ± 15 seconds for the first task and 18 ± 11 versus 32 ± 26 seconds for the second task). CONCLUSION AND CLINICAL RELEVANCE In both groups, the AL method significantly reduced the time to complete the task. Results from this study indicate that the AL method should be the preferred method for learning/teaching ultrasound-guided regional anaesthesia.
Collapse
|
234
|
Beyer K, Moris L, Gandaglia G, Lardas M, Healey J, Omar M, Zong J, Maclennan S, Briganti A, Van Hemelrijck M, Maclennan S. PIONEER consensus on clinician reported outcome measurements. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)36213-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
235
|
Surcel C, Mirvald C, Tsaur I, Borgmann H, Heidegger I, Labanaris AP, Sinescu I, Tilki D, Ploussard G, Briganti A, Montorsi F, Mathieu R, Valerio M, Jinga V, Badescu D, Radavoi D, van den Bergh RCN, Gandaglia G, Kretschmer A. Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer. World J Urol 2020; 39:2483-2490. [PMID: 33135127 DOI: 10.1007/s00345-020-03493-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Accepted: 10/10/2020] [Indexed: 11/30/2022] Open
Abstract
OBJECTIVE To access the feasibility of palliative cystoprostatectomy/pelvic exenteration in patients with bladder/rectal invasion due to prostate cancer (PC). PATIENTS AND METHODS Twenty-five men with cT4 PC were retrospectively identified in the institutional databases of six tertiary referral centers in the last decade. Local invasion was documented by CT or MRI scans and was confirmed by urethrocystoscopy. Oncological therapies, local symptoms, previous local treatments, time from diagnosis to intervention and type of surgical procedure were recorded. Patients were divided into groups: ADT group (12 pts) and 13 pts without any history of previous local/systemic treatments for PCa (nonADT groups). Perioperative complications were classified using the Clavien-Dindo system. Overall survival (OS) was defined as the time from surgery to death from any cause. A Cox regression analysis, stratified for ISUP score and previous hormonal treatment (ADT) was also performed for survival analysis. RESULTS Ileal conduit was the main urinary diversion in both cohorts. For the entire cohort, complication rate was 44%. No significant differences regarding perioperative complications and complication severity between both subgroups were observed (p = 0.2). Median follow-up was 15 months (range 3-41) for the entire cohort with a median survival of 15 months (95% CI 10.1-19.9). In Cox regression analysis stratified for ISUP score, no statistically significant differences in OS in patients with and without previous ADT before cystectomy or exenteration were observed (HR 3.26, 95% CI 0.62-17.23, p = 0.164). CONCLUSION Palliative cystoprostatectomy and pelvic exenteration represent viable treatment options associated with acceptable morbidity and good short-term survival outcome.
Collapse
|
236
|
Ratti M, Gandaglia G, Leardini L, Mazzoleni Ferracini S, Sisca E, Derevianko A, Furnari F, Beyer K, Pellegrino F, Sorce G, Barletta F, Scuderi S, Omar M, Maclennan S, Zong J, Maclennan S, Aiyegbusi O, Van Hemelrijck M, N’Dow J, Briganti A. Identifying the most appropriate instrument for Patient-Reported Outcome Measures (PROMs) in patients with clinically localised prostate cancer. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)36193-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
237
|
Colandrea G, Larcher A, Rosiello G, Muttin F, Baiamonte G, Re C, Rigatti P, Guazzoni G, Karakiewicz P, Mottrie A, Dehò F, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U. Pre-operative risk calculator of the probability of completing nephron-sparing surgery for kidney cancer: The key role of surgical experience and approach. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35479-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
238
|
Basile G, Bandini M, Zaffuto E, Scuderi S, Dehò F, Salonia A, Matloob R, Burgio G, Sciacqua L, Bertini R, Comana S, Moschini M, Zamboni S, Afferi L, Scattoni V, Colombo R, Briganti A, Montorsi F, Necchi A, Gallina A. Limited vs extended lymph node dissection in T1G3 bladder cancer patients treated with radical cystectomy: is this group responsible for the negative results of the LEA trial? EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35629-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
239
|
Fossati N, Karnes R, Boorjian S, Motterle G, Bossi A, Mazzone E, Cucchiara V, Scuderi S, Zito E, Gandaglia G, Kumar T, Di Muzio N, Cozzarini C, Chiorda B, Bartkowiak D, Shariat S, Goldner G, Devos G, Joniau S, Berghen C, De Meerleer G, Van Poppel H, Montorsi F, Wiegel T, Briganti A. Association between the extent of lymph node dissection and severe toxicity in men with prostate cancer treated with post-prostatectomy radiation therapy: results from a large multi-institutional series. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35565-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
240
|
Tutolo M, Gandaglia G, Fossati N, Cannoletta D, Menean M, Stabile A, Bianchi M, Barletta F, Pellegrino F, Zaffuto E, Cucchiara V, Van Der AA F, Van Cleynenbreuguel B, Bruyneel L, Tasso G, De Ridder D, Joniau S, Everaerts W, Salonia A, De Cobelli F, Esposito A, Mirone V, Montorsi F, Briganti A. Anatomical prostate mpMRI features and continence recovery after robot assisted radical prostatectomy: is there something beyond membranous urethral length? results from a large, multi-institutional cohort. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35583-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
241
|
Fossati N, Karnes R, Boorjan S, Motterle G, Bossi A, Kumar T, Di Muzio N, Cozzarini C, Chiorda B, Mazzone E, Bravi C, Stabile A, Gandaglia G, Cucchiara V, Bartkowiak D, Shariat S, Goldner G, Devos G, Joniau S, Berghen C, De Meerleer G, Van Poppel H, Montorsi F, Wiegel T, Briganti A. Cure without toxicity: development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35560-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
242
|
Martini A, Parikh A, Gandaglia G, Fossati N, Fallara G, Barletta F, Scuderi S, Robesti D, Cannoletta D, Leni R, Cucchiara V, Bravi C, Mazzone E, Rosiello G, Basile G, Nocera L, Necchi A, Moschini M, Sfakianos J, Galsky M, Oh W, Tsao C, Montorsi F, Briganti A. Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35563-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
243
|
Cignoli D, Martini A, Sfakianos J, Gandaglia G, Fossati N, Salonia A, Barletta F, Scuderi S, Robesti D, Bravi C, Mazzone E, Rosiello G, Fallara G, Nocera L, Cirulli G, Stabile A, Briganti A, Montorsi F, Oh W, Gallagher E, Galsky M. The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE trials. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35378-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
244
|
Mazzone E, Stabile A, Fossati N, Zaffuto E, Gandaglia G, Robesti D, Cannoletta D, Menean M, Cignoli D, Pellegrino F, Bravi C, Comana S, Cucchiara V, Fallara G, Dell’Oglio P, Martini A, Moschini M, Rizzo A, Necchi A, Salonia A, Karakiewicz P, Montorsi F, De Cobelli F, Briganti A. Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35384-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
245
|
Larcher A, Fallara G, Rosiello G, Basile G, Re C, Baiamonte G, Agnesi S, Cignoli D, Colandrea G, Briganti A, Bertini R, Salonia A, Montorsi F, Capitanio U. The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35525-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
246
|
Pellegrino F, Stabile A, Karnes R, Motterle G, Fossati N, Gandaglia G, Barletta F, Scuderi S, Cucchiara V, Robesti D, Rizzo A, Mazzone E, Rosiello G, Bravi C, Leni R, Moschini M, Brembilla G, Esposito A, Karakiewicz P, Montorsi F, De Cobelli F, Briganti A. Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era? EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35375-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
247
|
Marco B, Martini A, Pfail J, Gandaglia G, Fossati N, Scuderi S, Fallara G, Barletta F, Robesti D, Rizzo A, Basile G, Bravi C, Rosiello G, Nocera L, Stabile A, Gallina A, Salonia A, Montorsi F, Briganti A, Galsky M, Oh W. Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35564-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
248
|
Stabile A, Gandaglia G, Fossati N, Scuderi S, Barletta F, Nocera L, Leni R, Robesti D, Mazzone E, Rosiello G, Bandini M, Bravi C, Suardi N, Moschini M, Karakiewicz P, Macek P, Cathala N, Cathelineau X, Briganti A, Montorsi F, Salas R. Focal therapy for prostate cancer: do apical lesions correlate with worse outcomes? EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35555-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
249
|
Afferi L, Moschini M, Mattei A, Mordasini L, Abufaraj M, Soria F, D’Andrea D, Xylinas E, Seisen T, Colin P, Bensalah K, Pradere B, Mari A, Krajewski W, Alvarez-Maestro M, Kikuchi E, Chlosta P, Montorsi F, Briganti A, Simone G, Ornaghi P, Cerruto M, Antonelli A, Matsumoto K, Karakiewicz P, Shariat S. A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35625-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
250
|
Karakiewicz P, Rosiello G, Pecoraro A, Deuker M, Stolzenbach L, Tian Z, Larcher A, Montorsi F, Shariat S, Kapoor A, Saad F, Briganti A, Capitanio U. Prognostic differences in patients with T1a renal cell carcinoma according to clinical size. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35481-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|